Cargando…

Evaluation of the use of low-dose quetiapine and the risk of metabolic consequences: A retrospective review

INTRODUCTION: Quetiapine fumarate is an atypical antipsychotic approved for the treatment of schizophrenia, major depressive disorder, and bipolar disorder. Due to the sedative effects observed at low doses, prescribers use quetiapine to aid patients with sleep disturbances. Current evidence has est...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carr, Chelsea N., Lopchuk, Shruti, Beckman, Mary E., Baugh, Terrence Bradley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2016
Materias:	Open Submissions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007538/ https://www.ncbi.nlm.nih.gov/pubmed/29955487 http://dx.doi.org/10.9740/mhc.2016.11.308

Ejemplares similares

Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital
por: Gunterus, Alicia, et al.
Publicado: (2016)

Evaluation of adherence in patients prescribed long-acting injectable antipsychotics: A comparison of biweekly versus monthly administered neuroleptics
por: Carr, Chelsea N., et al.
Publicado: (2016)

A design and focus group evaluation of dietary choices tools for an underserved population
por: McMorris, Tressa, et al.
Publicado: (2016)

Implementation and evaluation of a pharmacist-run mental health treatment clinic via clinical video telehealth
por: Leach, Molly, et al.
Publicado: (2016)

Identification, assessment, and management of pain in patients with advanced dementia
por: Malotte, Kasey L., et al.
Publicado: (2016)

Evaluation of provider response to positive depression screenings and physician attitudes on integrating psychiatric pharmacist services in primary care settings
por: Denson, Brittany H., et al.
Publicado: (2018)

Evaluation of clinical pharmacy services within the primary care–mental health integration model at the Tuscaloosa Veterans Affairs Medical Center
por: Parikh, Mamta, et al.
Publicado: (2016)

A pilot study evaluating the effectiveness of a medicines education group in a mental health inpatient setting: A UK perspective
por: White, Daniel, et al.
Publicado: (2018)

Diuretics: A possible keystone in upholding cognitive health
por: DeLoach, Tyler, et al.
Publicado: (2018)

Outcomes of patient education practices to optimize the safe use of lithium: A literature review
por: Zolezzi, Monica, et al.
Publicado: (2018)

Mania possibly linked with bupropion for smoking cessation: A case report
por: Dwyer, Stephanie, et al.
Publicado: (2016)

A consumer-led intervention to improve pharmacists' attitudes toward mental illness
por: Rickles, Nathaniel M., et al.
Publicado: (2016)

Suicide prevention in pharmaceutical education: Raising awareness with inspiring stories
por: Vincent, Philippe D., et al.
Publicado: (2016)

Impact on length of stay and readmission rates when converting oral to long-acting injectable antipsychotics in schizophrenia or schizoaffective disorder
por: Chou, Fabienne, et al.
Publicado: (2016)

Hospitalizations and emergency room visits after initiation of long-acting injectable antipsychotics
por: Heesch, Chelsie B., et al.
Publicado: (2016)

Management of migraine headaches in a chronic pain patient: A case report
por: Bach, Linda Lu, et al.
Publicado: (2016)

Using Photovoice to explore patients' experiences with mental health medication: A pilot study
por: Werremeyer, Amy B., et al.
Publicado: (2016)

Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks
por: Tepper, Stewart J., et al.
Publicado: (2020)

Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses
por: Fiedler‐Kelly, Jill, et al.
Publicado: (2020)

Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing
por: Dodick, David W., et al.
Publicado: (2020)

No “Wearing‐Off Effect” Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long‐Term Study
por: Blumenfeld, Andrew M., et al.
Publicado: (2020)

Intravenous administration of mesenchymal stromal cells leads to a dose-dependent coagulopathy and is unable to attenuate acute traumatic coagulopathy in rats
por: Wu, Xiaowu, et al.
Publicado: (2022)

Rates of Vascular Events in Patients With Migraine: A MarketScan(®) Database Retrospective Cohort Study
por: Gill, Karminder, et al.
Publicado: (2020)

Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial
por: Croop, Robert, et al.
Publicado: (2022)

Real‐world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real‐world study
por: Gladstone, Jonathan, et al.
Publicado: (2021)

Acute kidney injury development in polytrauma and the safety of early repeated contrast studies: A retrospective cohort study
por: Giles, Thomas, et al.
Publicado: (2022)

Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo‐controlled randomized clinical trials
por: Schim, Jack D., et al.
Publicado: (2022)

The effect of needle size on cerebrospinal fluid collection time and post‐dural puncture headache: A retrospective cohort study
por: van Dongen, Robin M., et al.
Publicado: (2021)

The migraine signature study: Methods and baseline results
por: Pressman, Alice R., et al.
Publicado: (2020)

Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ)
por: Kawata, Ariane K., et al.
Publicado: (2019)

Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans
por: Jakate, Abhijeet, et al.
Publicado: (2020)

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine
por: Winner, Paul K., et al.
Publicado: (2020)

Evaluation of the 6‐item Identify Chronic Migraine screener in a large medical group
por: Pavlovic, Jelena M., et al.
Publicado: (2021)

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
por: Rothrock, John F., et al.
Publicado: (2019)

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial
por: Ailani, Jessica, et al.
Publicado: (2020)

Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention
por: Lipton, Richard B., et al.
Publicado: (2022)

Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes – The Migraine Functional Impact Questionnaire (MFIQ)
por: Hareendran, Asha, et al.
Publicado: (2018)

Evaluating associations between level of trauma care and outcomes of patients with specific severe injuries: A systematic review and meta-analysis
por: Van Ditshuizen, Jan C., et al.
Publicado: (2023)

Evaluation of vascular repair by tissue-engineered human acellular vessels or expanded polytetrafluoroethylene grafts in a porcine model of limb ischemia and reperfusion
por: Kirkton, Robert D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5hpvmis0cg6p8vddfhhtr8pmiv